Browsing Tag
Erez Israeli
4 posts
Dr. Reddy’s Laboratories to acquire Mayne Pharma’s US retail generics portfolio
Dr. Reddy’s Laboratories has agreed to acquire the US generic prescription product portfolio of Mayne Pharma Group, an…
Dr. Reddy’s Labs signs deal worth up to $150m to sell E7777 rights to Citius
Dr. Reddy’s Laboratories (Dr. Reddy’s Labs) has agreed to divest its rights to E7777, an engineered IL-2-diphtheria toxin…
Dr. Reddy’s Labs to sell certain rights for ELYXYB to BioDelivery Sciences
Dr. Reddy’s Laboratories (Dr. Reddy’s Labs) has agreed to divest its US and Canada rights for migraine drug…
Dr Reddy’s Laboratories to acquire generic injectable products in the US
Dr Reddy’s Laboratories has agreed to acquire a portfolio of 42 approved, non-marketed abbreviated new drug applications (ANDAs)…